簡易檢索 / 詳目顯示

研究生: 張書銘
論文名稱: A-T Rich DNA與新型胜肽的鍵結研究
The Binding Studies of A-T Rich DNA and a Novel Peptide
指導教授: 程家維
口試委員:
學位類別: 碩士
Master
系所名稱: 生命科學暨醫學院 - 生物科技研究所
Biotechnology
論文出版年: 2010
畢業學年度: 98
語文別: 中文
論文頁數: 53
中文關鍵詞: 核磁共振胜肽
相關次數: 點閱:2下載:0
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • DNA是生物體中重要的遺傳物質。其所攜帶的基因訊息,透過複製、轉錄,影響了細胞內重要的生化反應。許多特定的蛋白質會選擇性地作用到特定的DNA片段以調控這些反應。而許多小分子藥物因此被設計出來作用到DNA序列上,干擾蛋白質與DNA的作用,以達到抑制癌症與相關疾病的目的。在本次研究中,我們以XPRK motif與pyrrole設計出新型胜肽,序列為Gln-Hyp-Arg-Lys-(Py)4-Arg-Lys-NH2 (HyQ-10),並以d(AGGAGAAAATAC)2雙股螺旋DNA當做我們的目標片段。藉由NMR二維光譜,我們解析出d(AGGAGAAAATAC)2的序列資訊。在HyQ10的滴定實驗中,我們發現隨著滴定比例的增加,靠近A/T連續位置的影響越強,其中又以T連續的位置鍵結最穩定。而在滴定過程中,我們只發現一組新的交叉峰型式,顯示HyQ-10與DNA可能只有一種結合模式。


    DNA is an important molecule in the organism. The genetic information carried by DNA regulates important biochemical reactions by replication and transcription. Many proteins selectively bind to DNA fragment to regulate these reactions. Therefore, many small molecules were designed to recognize these specific DNA sequences to block the interaction between proteins and DNA and to inhibit cancer and other disease. In this study, we designed a novel peptide contains the XPRK motif and Py residue. The sequence of the designed peptide is Gln-Hyp-Arg-Lys-(Py)4-Lys-Arg-NH2 (HyQ-10). We chose a duplex d(AGGAGAAAATAC)2 as our target. By 2D NMR spectroscopy, we got the sequential assignment of d(AGGAGAAAATAC)2. In the HyQ-10 titraion experiment, we find out that the residues around the A/T-rich site will get the larger influence. And the consecutive T site has the most stable binding. In the titration experiment, we only found out a new cross peak mode, indicating that HyQ-10 and d(AGGAGAAAATAC)2 may have only one binding mode.

    目錄 2 圖表目次 3 誌謝 5 中文摘要 6 Abstract 7 第一章 序論 8 1.1 DNA簡介 8 1.2 DNA小溝槽與相關的藥物 9 1.3 小分子藥物與DNA小溝槽結合的相關研究 9 1.4 研究動機 10 第二章 材料與方法 13 2.1 NMR實驗樣品製備 -- d(AGGAGAAAATAC)2 13 2.1.1 吸收係數測定 13 2.2 NMR實驗樣品製備 -- d(AGGAGAAAATAC)2/HyQ-10複合物 13 2.3 核磁共振原理 14 2.4 NMR實驗 – d(AGGAGAAAATAC)2 17 2.5 NMR實驗–d(AGGAGAAAATAC)2/HyQ-10複合物 18 2.6 光譜處理 18 2.7 光譜數據的分析 18 第三章 實驗結果 20 3.1 d(AGGAGAAAATAC)2 20 3.1.1 一維光譜分析 20 3.1.2 二維光譜分析 20 3.1.2.1 確認非交換性質子(non-exchangeable proton) 20 3.1.2.2 確認可交換性質子(exchangeable proton) 21 3.2 d(AGGAGAAAATAC)2/HyQ-10複合物 22 3.2.1 一維光譜分析 22 3.2.2 二維光譜分析 22 3.2.2.1 DNA訊號變化 22 3.2.2.2 HyQ-10與DNA作用的訊號變化 24 第四章 討論 25 參考文獻 27

    1.Dervan P.B., Doss R.M., Marques M.A. (2005) Curr. Med. Chem. - Anti-Cancer Agents 5, 373-387
    2.Neidle S. (2001) Nat. Prod. Rep. 18, 291-309
    3.Arcamone, F., Penco S., Orezzi P., Nicolella V., and Pirelli A.. (1964) Nature (London) 203, 1064-1065
    4.Finlay A.C., Hochstein F. A., Sobin B.A., Murphy F.X. (1951) J. Am. Chem. Soc. 73, 341-343
    5.Dwyer T.J., Geierstanger B.H., Bathini Y.L., Lown J. W., Wemmer D.E. (1994) J. Am. Chem. Soc. 114, 5911-5919
    6.Pelton J.G., Wemmer D.E. (1989) Proc. Natl. Acad. Sci. USA 86, 5723-5727
    7.Pelton J.G. Wemmer D.E. (1990) J. Am. Chem. Soc. 112, 1393-1399
    8.Kopka M.L., Yoon C., Goodsell D., Pjura P., Dickerson R.E. (1985) Proc. Natl. Acad. Sci. USA 82, 1376-1380
    9.Mackay H., Brown T., Uthe P.B., Westrate L., Sielaff A., Jones J., Lajiness J.P., Kluza J., O'Hare C., Nguyen B., Davis Z., Bruce C., Wilson W.D., Hartley J.A., Lee M. (2008) Bioorg. Med. Chem 16, 9145-9153
    10.Dose C., Farkas M.E., Chenoweth D.M., Dervan P.B. (2008) J. Am. Chem. Soc. 130, 6859-6866
    11.Zhang Q., Dwyer T.J., Tsui V., Case D.A., Cho J., Dervan P.B., Wemmer D.E. (2004) J. Am. Chem. Soc. 126, 7958-7966
    12.Suzuki M. (1988) Proc. Japan Acad. 64, 29-32
    13.Suzuki M. (1988) Proc. Japan Acad. 64, 33-36
    14.Churchill M.E.A., Suzuki M. (1989) The EMBO Journal 8, 4189-4195
    15.Suzuki M. (1989) The EMBO Journal 8, 797-804
    16.Suzuki M. (1990) Nature 344, 562-565
    17.Suzuki M., Yagi N. (1991) Proc. R. Soc. Lond. B 246, 231-235
    18.Kumaki Y., Matsushima N., Yoshida H., Nitta K., Hikichi K. (2001) Biochim. Biophys. Acta. 1548, 81-93
    19.Yang C.H., Chou P.J., Luo Z.L., Chou I.C., Chang J.C., Cheng C.C., Martin C.R.H., Waring M.J., Sheh L. (2003) Bioorg. Med. Chem. 11, 3279-3288
    20.Chang J.C., Yang C.H., Chou P.Y., Yang W.H., Chou I.C., Lu C.T., Lin P.H., Hou R.C.W., Jeng K.C.G., Cheng C.C., Sheh L. (2004) Bioorg. Med. Chem. 12, 53-61
    21.Kao K.K., Huang J.C.T., Yang C.K., Jeng K.C.G., Chang J.C., Yao W.C., Hsien S.C., Waring M.J., Chen M.H., Ma L., Shen L. (2010) Bioorg. Med. Chem. 18, 366-376
    22.Huang J.T.B., Chen Y.C., Chang J.C., Jeng K.C.G., Kao K.K.L., Yang R.C.K., Kan L.S., Wey M.T., Waring M.J., Chen C.S., Chien W.J., Sheh L. (2010) Bioorg. Med. Chem. 18, 2575-2585
    23.Luscombe N.M., Laskowski R.A., Thornton J.M. (2001) Nucleic Acids Research 29, 2860-2874
    24.Hare D. E., Wemmer, D. E., Chou, S. H., Drobny, G. & Reid, B. R. (1983) J. Mol. Biol. 171, 319-336
    25.Wuthrich K., NMR of Proteins and Nucleic Acid. 1986, New York, USA: John Wiley & Sons.
    26.Kintanar A., Klevit R.E., Brian R.R. (1987) Nucleic Acids Research 15, 5845-5862
    27.Baleja J.D., Pon R.T., Sykes B.D. (1990) Biochemistry 29, 4828-4839
    28.Geierstanger B.H., Dwyer T.J., Bathini Y., Lown J.W., Wemmer D.E. (1993) J. Am. Chem. Soc. 115, 4474-4482
    29.Clairac R.P.L., Geierstanger B.H., Mrksich M., Dervan P.B., Wemmer D.E. (1997) J. Am. Chem. Soc. 119, 7909-7916

    無法下載圖示 全文公開日期 本全文未授權公開 (校內網路)
    全文公開日期 本全文未授權公開 (校外網路)
    全文公開日期 本全文未授權公開 (國家圖書館:臺灣博碩士論文系統)
    QR CODE